Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
Sumatriptan Tablet
Product Images NDC 63187-969
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 63187-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)
63187-969-09 (Sumatriptan Fig3)
This is a medication bottle containing sumatriptan, a prescription medication commonly used to treat migraines. Each tablet contains 25mg of sumatriptan succinate. The bottle contains 9 tablets with a product ID of RS096909. The tablets are white or off-white, round, and uncoated with a "C" on one side and "32" on the other. The medication was manufactured by Aurobindo Pharma Limited in India and relabeled by Proficient Rx LP in Thousand Oaks, California. The bottle should be stored at 20°-25°C (68°-77°F) and kept out of the reach of children. The bottle's lot number is 0000, and it has an expiration date of 00/00/00. GTIN: 0363187969097.*
Chemical Structure (Sumatriptan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
